Dudediligence.

PMV Pharmaceuticals, Inc

PMVPNASDAQ · Pharmaceutical Preparations
Write an idea

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

53.5M

on 2026-06-30, from 51.4M on 2024-03-31 10-Q ↗

a raise that quarter, at its price

20M40MMar2024JunSepDecMar2025JunSepDecMar2026Jun

Newest

S-3 of 2024-11-20. Not read yet. S-3 ↗

$113.8M

Jefferies, agreement of 2021-10-04. No at-the-market sales statement read from a 10-Q or 10-K. 424B3 ↗

Warrants

The 10-Q filed 2026-08-14 is not read yet.

Cash

4.5 quarters

$79.4M on 2026-06-30 ÷ $17.8M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
DateWhatSharesPriceGrossFiling
2026-08-31Public offering incl. 19.90M pre-funded41,955,000$1.21$50.8M424B5 ↗